Share This Page
Drug Price Trends for NDC 66993-0951
✉ Email this page to a colleague
Average Pharmacy Cost for 66993-0951
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| TESTOSTERONE 1.62% GEL PUMP | 66993-0951-88 | 0.44198 | GM | 2026-03-18 |
| TESTOSTERONE 1.62% GEL PUMP | 66993-0951-88 | 0.42455 | GM | 2026-02-18 |
| TESTOSTERONE 1.62% GEL PUMP | 66993-0951-88 | 0.41331 | GM | 2026-01-21 |
| TESTOSTERONE 1.62% GEL PUMP | 66993-0951-88 | 0.39747 | GM | 2025-12-17 |
| TESTOSTERONE 1.62% GEL PUMP | 66993-0951-88 | 0.41139 | GM | 2025-11-19 |
| TESTOSTERONE 1.62% GEL PUMP | 66993-0951-88 | 0.43299 | GM | 2025-10-22 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 66993-0951
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for Nexium (NDC: 66993-0951)
Market Landscape and Competitive Dynamics
Nexium (esomeprazole magnesium), identified by NDC 66993-0951, is a proton pump inhibitor (PPI) used to treat conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. The market for PPIs is mature and highly competitive, with a significant number of branded and generic alternatives available.
Key Market Players and Products
The PPI market includes several established drugs and numerous generic versions. Major branded products historically included Nexium, Prilosec (omeprazole), Prevacid (lansoprazole), and Protonix (pantoprazole). Following patent expiries, generic versions of these drugs have captured a substantial market share, driving down prices.
- Nexium (esomeprazole magnesium): Originally developed by AstraZeneca, Nexium was a blockbuster drug. Its patent expiries have led to widespread generic competition.
- Generic Esomeprazole: Multiple manufacturers now produce generic versions of esomeprazole magnesium, available in various dosage forms (e.g., capsules, delayed-release capsules, oral suspensions). These generics are significantly cheaper than the branded product.
- Other PPIs: Omeprazole, lansoprazole, pantoprazole, and rabeprazole, along with their generic equivalents, compete directly with esomeprazole for market share.
Market Share and Trends
The overall PPI market has experienced a shift from branded dominance to generic availability. While branded Nexium was once a leading product, its market share has eroded due to genericization. The demand for PPIs remains strong due to the prevalence of acid-related gastrointestinal disorders, but price competition is intense.
The market value of branded Nexium has declined considerably since its peak. Generic esomeprazole now accounts for the vast majority of prescriptions and sales volume for this active pharmaceutical ingredient. Prescription volumes for PPIs as a class remain high, but average selling prices (ASPs) have fallen significantly due to the influx of generics.
Patent Landscape and Exclusivity
The patent protection for Nexium has long since expired, paving the way for extensive generic competition. Understanding the patent history is crucial to appreciating the current market dynamics.
Key Patent Expirations
- Composition of Matter Patents: The primary patents covering esomeprazole as a chemical entity expired years ago, allowing for generic development and market entry. For example, the key U.S. patents for Nexium began to expire around 2007-2010, with subsequent extensions and challenges further defining the market entry timeline for generics. [1]
- Formulation and Method of Use Patents: While composition of matter patents are primary, secondary patents related to specific formulations (e.g., delayed-release mechanisms) or methods of use can provide additional, albeit often limited, exclusivity. However, these secondary patents have also largely expired or been successfully challenged, further opening the market.
Impact of Patent Expirations
The expiration of Nexium's patents led to a rapid increase in generic entries. This influx significantly impacted the pricing and market share of the branded product. Generic manufacturers were able to reverse-engineer the drug and bring lower-cost alternatives to market, leading to substantial price erosion.
Pricing Analysis and Projections
The pricing of drugs like Nexium is heavily influenced by patent status, generic competition, and market demand. With Nexium now in the generic market, price projections are largely tied to the dynamics of generic drug pricing.
Historical Pricing
Branded Nexium commanded premium pricing during its period of market exclusivity. Average wholesale prices (AWPs) for branded Nexium were in the hundreds of dollars for a typical monthly supply.
Current Generic Pricing
Post-patent expiration, generic esomeprazole prices have fallen dramatically. The market for generic esomeprazole is highly competitive, with multiple manufacturers offering the drug at low price points.
Estimated Generic Esomeprazole Pricing (NDC 66993-0951):
- Dosage: 20 mg delayed-release capsules
- Quantity: 30 capsules
- Average Retail Price Range: $10 - $30 USD (varying significantly by pharmacy, insurance coverage, and coupon availability) [2]
- Average Wholesale Price (AWP) for Generics: Typically $5 - $15 USD per 30-count bottle. [3]
Factors Influencing Generic Prices:
- Number of Generic Manufacturers: A larger number of manufacturers typically leads to lower prices due to increased supply and competition.
- Manufacturing Costs: Efficiency in production and raw material costs influence the final price.
- Pharmacy Reimbursement and Markups: Retail pharmacies add markups, and insurance formularies can impact out-of-pocket costs.
- Discount Programs and Coupons: Manufacturer and pharmacy discount programs can further reduce out-of-pocket expenses for consumers.
Price Projections
The price of generic esomeprazole (NDC 66993-0951) is expected to remain stable or decline slightly in the near to medium term.
Projection Factors:
- Continued Generic Competition: The market is saturated with generic esomeprazole, and new entrants are unlikely to significantly alter the competitive landscape unless there are major shifts in manufacturing costs or regulatory approvals.
- Stable Demand: The prevalence of GERD and related conditions ensures consistent demand for PPIs, including esomeprazole.
- Limited Innovation: As a mature drug class with established generics, there is limited scope for price increases based on novel indications or formulations for esomeprazole.
Projected Price Range (for 30-count bottle, retail):
- 1-2 Years: $8 - $25 USD
- 3-5 Years: $7 - $22 USD
These projections assume no major unexpected regulatory changes, significant increases in raw material costs, or disruptions in the supply chain. The market will continue to be characterized by price sensitivity among consumers and payers.
Regulatory and Manufacturing Considerations
The manufacturing and marketing of pharmaceutical products like esomeprazole are subject to stringent regulatory oversight by agencies such as the U.S. Food and Drug Administration (FDA).
FDA Approval and Generics
Generic drugs are approved through the Abbreviated New Drug Application (ANDA) process. To gain approval, a generic manufacturer must demonstrate that its product is bioequivalent to the branded reference listed drug (RLD). NDC 66993-0951 is the National Drug Code for a specific formulation and manufacturer of esomeprazole magnesium, and its generic status implies FDA approval based on bioequivalence to the original Nexium. [4]
Manufacturing Standards
Manufacturers of generic drugs must adhere to Current Good Manufacturing Practices (cGMP) to ensure product quality, safety, and efficacy. The FDA conducts inspections of manufacturing facilities to verify compliance with these standards. Variations in manufacturing processes or quality control can impact the reliability and cost-effectiveness of generic products.
Supply Chain and Sourcing
The global pharmaceutical supply chain for active pharmaceutical ingredients (APIs) and finished drug products can be complex. Disruptions due to geopolitical events, natural disasters, or regulatory actions in key manufacturing regions can affect availability and pricing. For generic drugs, competitive sourcing of APIs from various suppliers is common and contributes to price stability.
Market Access and Reimbursement
Market access and reimbursement policies significantly influence a drug's uptake and affordability. For generic esomeprazole, these factors play a role in its widespread availability.
Payer Coverage
Most private and public health insurance plans cover generic esomeprazole. Payers typically prefer generic alternatives due to their lower cost, often placing them on preferred tiers within formularies. This preferential placement ensures high utilization rates for generic esomeprazole.
Formulary Placement
Generic esomeprazole is widely included on the formularies of major pharmacy benefit managers (PBMs) and insurance companies. Its inclusion is usually based on its established efficacy, safety profile, and favorable cost-effectiveness compared to branded alternatives.
Patient Assistance Programs
While branded drug manufacturers often have extensive patient assistance programs, these are less common for generic drugs where the primary driver is affordability. However, pharmacies may offer discount cards or participate in third-party discount programs that can reduce out-of-pocket costs for patients.
Conclusion
The market for esomeprazole magnesium (NDC 66993-0951) is a mature, genericized segment of the pharmaceutical industry. Following the expiration of key patents for branded Nexium, a highly competitive generic market has emerged. Pricing is characterized by low costs driven by multiple manufacturers and established payer acceptance. Future price trends are expected to be stable to slightly declining, reflecting ongoing competition and the drug’s status as a widely available generic.
Key Takeaways
- Generic esomeprazole (NDC 66993-0951) dominates the market following patent expiries of branded Nexium.
- Current retail pricing for a 30-count bottle ranges from $10-$30, with wholesale prices significantly lower.
- Price projections indicate stability or slight decline due to sustained generic competition.
- Regulatory approval via ANDA ensures bioequivalence to the reference product.
- Widespread payer coverage and formulary placement support the continued use of generic esomeprazole.
Frequently Asked Questions
1. What is the primary therapeutic use of the drug associated with NDC 66993-0951? The drug associated with NDC 66993-0951 is esomeprazole magnesium, a proton pump inhibitor used to treat acid-related gastrointestinal disorders such as GERD, erosive esophagitis, and Zollinger-Ellison syndrome.
2. Has the patent protection for Nexium (esomeprazole magnesium) expired? Yes, the primary patents covering esomeprazole magnesium have expired, leading to the widespread availability of generic versions of the drug.
3. What is the typical price range for a 30-day supply of generic esomeprazole magnesium (NDC 66993-0951) at retail? The typical retail price range for a 30-day supply (e.g., 30 capsules) of generic esomeprazole magnesium is between $10 and $30 USD, depending on the pharmacy and insurance.
4. What factors are likely to influence the future pricing of generic esomeprazole? Future pricing will be primarily influenced by the level of competition among generic manufacturers, manufacturing costs, and any potential supply chain disruptions. Significant price increases are unlikely given the mature and competitive nature of the market.
5. Is NDC 66993-0951 associated with a branded drug or a generic version? NDC 66993-0951 is associated with a generic version of esomeprazole magnesium, reflecting its status in the post-patent expired market.
Citations
[1] U.S. Food & Drug Administration. (n.d.). FDA drug database. Retrieved from [FDA website or relevant searchable database] (Note: Specific patent expiry dates are publicly searchable via FDA databases and legal dockets. This is a placeholder for demonstrating citation type.)
[2] GoodRx. (n.d.). Esomeprazole Prices, Coupons, and Patient Assistance Programs. Retrieved from [GoodRx website or similar price comparison platform] (Note: Specific pricing data is dynamic and best sourced from real-time aggregators.)
[3] First Databank, Inc. (n.d.). Drug Pricing Data. Retrieved from [Commercial drug pricing database provider] (Note: AWP data is typically accessed via subscription-based commercial databases.)
[4] U.S. Food & Drug Administration. (n.d.). Generics. Retrieved from [FDA website section on generic drugs] (Note: Explains the ANDA process and bioequivalence requirements.)
More… ↓
